Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis

Bennett, 1974, Nosocomial infections due to pseudomonas, Journal of Infectious Diseases, 130, S4, 10.1093/infdis/130.Supplement.S4 Bodey, 1983, Infections caused by Pseudomonas aeruginosa, Reviews of Infectious Diseases, 5, 279, 10.1093/clinids/5.2.279 Brokopp, 1977, Serological typing of Pseudomonas aeruginosa: use of commercial antisera and live antigens, Journal of Clinical Microbiology, 5, 640, 10.1128/jcm.5.6.640-649.1977 Diaz, 1970, Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis, Journal of Infectious Diseases, 121, 269, 10.1093/infdis/121.3.269 Doggett, 1969, Incidence of mucoid Pseudomonas aeruginosa from clinical sources, Applied Microbiology, 18, 936, 10.1128/AEM.18.5.936-937.1969 Hancock, 1983, Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, non-typable strains deficient in lipopolysaccharide O side-chains, Infection and Immunity, 42, 170, 10.1128/IAI.42.1.170-177.1983 Høiby, 1977, Pseudomonas aeruginosa infections in cystic fibrosis, Acta Pathologika et Mikrobiologika Scandinavika Sect. C, 85, 107 Høiby, 1980, Epidemiology of Pseudomonas aeruginosa infection in patients treated at a cystic fibrosis centre, Acta Pathologika et Mikrobiologika Scandinavika Sect B, 88, 125 Kelly, 1982, Does pseudomonas cross-infection occur between cystic fibrosis patients?, Lancet, ii, 688, 10.1016/S0140-6736(82)90714-0 Laraya-Cuasay, 1976, Pseudomonas carrier rates of patients with cystic fibrosis and of members of their families, Journal of Pediatrics, 89, 23, 10.1016/S0022-3476(76)80920-1 Maki, 1982, Relation of the inanimate hospital environment to endemic nosocomial infection, New England Journal of Medicine, 307, 1562, 10.1056/NEJM198212163072507 Marks, 1981, The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis, Journal of Pediatrics, 98, 173, 10.1016/S0022-3476(81)80631-2 McLaughlin, 1983, Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo, Journal of Infectious Diseases, 149, 559, 10.1093/infdis/147.3.559 Penketh, 1983, The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis, American Review of Respiratory Diseases, 127, 605, 10.1164/arrd.1983.127.5.605 Pitt, 1980, State of the art: typing Pseudomonas aeruginosa, Journal of Hospital Infection, 1, 193, 10.1016/0195-6701(80)90056-0 Rabin, 1980, Evaluation of a high dose tobramycin and ticarcillin treatment protocol in cystic fibrosis based on improved susceptibility criteria and antibiotic pharmacokinetics, 370 Reynolds, 1975, Pseudomonas aeruginosa infections: persisting problems and current research to find new therapies, Annals of Internal Medicine, 82, 819, 10.7326/0003-4819-82-6-819 Speert, 1982, Communicability of Pseudomonas aeruginosa in a cystic fibrosis summer camp, Journal of Pediatrics, 101, 227, 10.1016/S0022-3476(82)80127-3 Thomassen, 1981, Serum bactericidal effect on Pseudomonas aeruginosa isolates from cystic fibrosis patients, Infection and Immunity, 33, 512, 10.1128/IAI.33.2.512-518.1981 Thomassen, 1979, Multiple isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis, Journal of Infectious Diseases, 140, 873, 10.1093/infdis/140.6.873 Thomassen, 1985, Pseudomonas aeruginosa isolates: comparisons of isolates from campers and from sibling pairs with cystic fibrosis, Pediatric Pulmonology, 1, 40, 10.1002/ppul.1950010110 Wahba, 1965, The identification of atypical strains of Pseudomonas aeruginosa, Journal of General Microbiology, 38, 329, 10.1099/00221287-38-3-329 Whitby, 1972, Pseudomonas aeruginosa contamination in domestic and hospital environments, Lancet, i, 15, 10.1016/S0140-6736(72)90006-2 Wood, 1976, Cystic fibrosis, American Review of Respiratory Diseases, 113, 833 Woods, 1980, Role of adherence in the pathogenesis of Pseudomonas aeruginosa lung infection in cystic fibrosis patients, Infection and Immunity, 30, 694, 10.1128/iai.30.3.694-699.1980 Zierdt, 1975, Serotyping of Pseudomonas aeruginosa isolates from patients with cystic fibrosis of the pancreas, Journal of Clinical Microbiology, 1, 521, 10.1128/JCM.1.6.521-526.1975 Zimakoff, 1983, Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic, Journal of Hospital Infection, 4, 31, 10.1016/0195-6701(83)90062-2